Literature DB >> 2788579

Identification and characterization of 114/A10, an antigen highly expressed on the surface of murine myeloid and erythroid progenitor cells and IL-3-dependent cell lines.

G J Dougherty1, S T Dougherty, R J Kay, P Landsdorp, R K Humphries.   

Abstract

Monoclonal antibody (mAb) 114/A10, raised against the murine bone marrow-derived multipotential hemopoietic progenitor cell line B6SUtA, identifies an antigen highly expressed by various interleukin-3 (IL-3)-dependent cell lines, the myelomonocytic cell line WEHI-3, and a large proportion of primary myeloid and erythroid colony-forming cells. Spleen- and bone marrow-derived 114/A10-positive cells were shown to selectively proliferate in vitro in response to pokeweed mitogen-stimulated spleen cell-conditioned medium or recombinant IL-3. Western blot analysis indicated that the antigen recognized by mAb 114/A10 has a mean relative molecular mass of approximately 150,000, although it is extremely heterogeneous in nature, and differs greatly in size range among different cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788579

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  4 in total

1.  From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs.

Authors:  A V Terskikh; M C Easterday; L Li; L Hood; H I Kornblum; D H Geschwind; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.

Authors:  G J Dougherty; P M Landorp; D L Cooper; R K Humphries
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

3.  Outcomes of Sacral Neuromodulation in a Privately Insured Population.

Authors:  Jennifer T Anger; Anne P Cameron; Rodger Madison; Christopher Saigal; J Quentin Clemens
Journal:  Neuromodulation       Date:  2016-08-05

4.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Authors:  G Krosl; M Korbelik; G J Dougherty
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.